Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

288P - Non-metastatic adenosquamous lung carcinoma disparities by ethnicity and income

Date

28 Mar 2025

Session

Poster Display session

Presenters

Inae Park

Citation

Journal of Thoracic Oncology (2025) 20 (3): S163-S180. 10.1016/S1556-0864(25)00632-X

Authors

I. Park

Author affiliations

  • Montefiore Medical Center - Moses Campus, Bronx/US

Resources

This content is available to ESMO members and event participants.

Abstract 288P

Background

Adenosquamous lung carcinoma (ASC) is a rare subtype of invasive lung cancer which accounts for up to four percent of overall invasive lung cancer in the United States. The clinical features of ASC have not been fully understood due to limited patient data. Here, we report disparities by ethnicity and income in patients with ASC.

Methods

The overall survival (OS) was obtained from the Surveillance, Epidemiology, and End Results (SEER) Stat Database 17-registry between 2000–2021. Univariate and multivariate logistic regression analyses were used for the patients with non-metastatic adenosquamous lung carcinoma (Stage I, II, and III) without neoadjuvant chemotherapy. The combined SEER staging and the 3rd, 6th, 7th, and 8th edition of American Joint Committee on Cancer (AJCC) staging were used. Patient subgroups were divided into ethnicity (Hispanic, non-hispanic white; NHW, non-hispanic black; NHB, non-hispanic others; NHO), household income (≥$75,000 vs

Results

Overall, 3,771 patients were included in the final analysis. The independent prognostic factors were age of diagnosis, race, stage, differentiation grade, primary surgery, chemotherapy, radiation, income, and marital status. In ethnic subgroups, the Hispanic subgroup showed better OS than in NHB subgroup (HR 1.19, 95% CI, 1.00–1.43). Hispanic and NHW patients did not reveal significant differences in OS. (HR 1.00, 95% CI, 0.87–1.16). In geographic subgroups, patients in the metropolitan areas did not show significant difference in OS compared to patients in nonmetropolitan areas (HR 0.92, 95% CI, 0.83–1.01). In income subgroups, patients with household income ≥$75,000 revealed better OS than those who have income less than $75,000 (HR 0.82, 95% CI, 0.76–0.88).

Conclusions

Overall, mortality and OS varied among different ethnic groups and regions, though additional studies are warranted for Native Americans or Alaskans with a larger patient dataset. In regards to primary prevention, an early intervention could be especially beneficial for patients in low income. Furthermore, several possible confounding factors such as alcohol or smoking could be further controlled.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.